Global Influenza A/B Nucleic Acid Detection Kit Market Outlook, In-Depth Analysis & Forecast to 2031

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Introduction to Influenza A/B Nucleic Acid Detection Kit: Definition, Properties, and Key Attributes
• 1.2 Market Segmentation by Type
  • 1.2.1 Global Influenza A/B Nucleic Acid Detection Kit Market Size by Type, 2020 VS 2024 VS 2031
  • 1.2.2 32 Test/ Box
  • 1.2.3 96 Test/ Box
  • 1.2.4 Other Packaging Specifications
• 1.3 Market Segmentation by Application
  • 1.3.1 Global Influenza A/B Nucleic Acid Detection Kit Market Size by Application, 2020 VS 2024 VS 2031
  • 1.3.2 Hospital
  • 1.3.3 CDC
  • 1.3.4 Third-party Testing Agency
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global Influenza A/B Nucleic Acid Detection Kit Revenue Estimates and Forecasts 2020-2031
• 2.2 Global Influenza A/B Nucleic Acid Detection Kit Revenue by Region
  • 2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
  • 2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
  • 2.2.3 Global Revenue Market Share by Region (2020-2031)
• 2.3 Global Influenza A/B Nucleic Acid Detection Kit Sales Estimates and Forecasts 2020-2031
• 2.4 Global Influenza A/B Nucleic Acid Detection Kit Sales by Region
  • 2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
  • 2.4.2 Historical and Forecasted Sales by Region (2020-2031)
  • 2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
  • 2.4.4 Global Sales Market Share by Region (2020-2031)

3 Competition by Manufacturers

• 3.1 Global Influenza A/B Nucleic Acid Detection Kit Sales by Manufacturers
  • 3.1.1 Global Sales Volume by Manufacturers (2020-2025)
  • 3.1.2 Global Top 5 and Top 10 Manufacturers'Market Share by Sales Volume (2024)
• 3.2 Global Influenza A/B Nucleic Acid Detection Kit Manufacturer Revenue Rankings and Tiers
  • 3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
  • 3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
  • 3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
• 3.3 Manufacturer Profitability Profiles and Pricing Strategies
  • 3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
  • 3.3.2 Manufacturer-Level Price Trends (2020-2025)
• 3.4 Key Manufacturers Manufacturing Base and Headquarters
• 3.5 Main Product Type Market Size by Manufacturers
  • 3.5.1 32 Test/ Box Market Size by Manufacturers
  • 3.5.2 96 Test/ Box Market Size by Manufacturers
  • 3.5.3 Other Packaging Specifications Market Size by Manufacturers
• 3.6 Global Influenza A/B Nucleic Acid Detection Kit Market Concentration and Dynamics
  • 3.6.1 Global Market Concentration (CR5 and HHI)
  • 3.6.2 Entrant/Exit Impact Analysis
  • 3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Global Product Segmentation Analysis

• 4.1 Global Influenza A/B Nucleic Acid Detection Kit Sales Performance by Type
  • 4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
  • 4.1.2 Global Sales Market Share by Type (2020-2031)
• 4.2 Global Influenza A/B Nucleic Acid Detection Kit Revenue Trends by Type
  • 4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
  • 4.2.2 Global Revenue Market Share by Type (2020-2031)
• 4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
• 4.4 Product Technology Differentiation
• 4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
  • 4.5.1 High-Growth Niches and Adoption Drivers
  • 4.5.2 Profitability Hotspots and Cost Drivers
  • 4.5.3 Substitution Threats

5 Global Downstream Application Analysis

• 5.1 Global Influenza A/B Nucleic Acid Detection Kit Sales by Application
  • 5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
  • 5.1.2 Global Sales Market Share by Application (2020-2031)
  • 5.1.3 High-Growth Application Identification
  • 5.1.4 Emerging Application Case Studies
• 5.2 Global Influenza A/B Nucleic Acid Detection Kit Revenue by Application
  • 5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
  • 5.2.2 Revenue Market Share by Application (2020-2031)
• 5.3 Global Pricing Dynamics by Application (2020-2031)
• 5.4 Downstream Customer Analysis
  • 5.4.1 Top Customers by Region
  • 5.4.2 Top Customers by Application

6 North America

• 6.1 North America Sales Volume and Revenue (2020-2031)
• 6.2 North America Key Manufacturers Sales Revenue in 2024
• 6.3 North America Influenza A/B Nucleic Acid Detection Kit Sales and Revenue by Type (2020-2031)
• 6.4 North America Influenza A/B Nucleic Acid Detection Kit Sales and Revenue by Application (2020-2031)
• 6.5 North America Growth Accelerators and Market Barriers
• 6.6 North America Influenza A/B Nucleic Acid Detection Kit Market Size by Country
  • 6.6.1 North America Revenue by Country
  • 6.6.2 North America Sales Trends by Country
  • 6.6.3 US
  • 6.6.4 Canada
  • 6.6.5 Mexico

7 Europe

• 7.1 Europe Sales Volume and Revenue (2020-2031)
• 7.2 Europe Key Manufacturers Sales Revenue in 2024
• 7.3 Europe Influenza A/B Nucleic Acid Detection Kit Sales and Revenue by Type (2020-2031)
• 7.4 Europe Influenza A/B Nucleic Acid Detection Kit Sales and Revenue by Application (2020-2031)
• 7.5 Europe Growth Accelerators and Market Barriers
• 7.6 Europe Influenza A/B Nucleic Acid Detection Kit Market Size by Country
  • 7.6.1 Europe Revenue by Country
  • 7.6.2 Europe Sales Trends by Country
  • 7.6.3 Germany
  • 7.6.4 France
  • 7.6.5 U.K.
  • 7.6.6 Italy
  • 7.6.7 Russia

8 Asia-Pacific

• 8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
• 8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
• 8.3 Asia-Pacific Influenza A/B Nucleic Acid Detection Kit Sales and Revenue by Type (2020-2031)
• 8.4 Asia-Pacific Influenza A/B Nucleic Acid Detection Kit Sales and Revenue by Application (2020-2031)
• 8.5 Asia-Pacific Influenza A/B Nucleic Acid Detection Kit Market Size by Region
  • 8.5.1 Asia-Pacific Revenue by Region
  • 8.5.2 Asia-Pacific Sales Trends by Region
• 8.6 Asia-Pacific Growth Accelerators and Market Barriers
• 8.7 Southeast Asia
  • 8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
  • 8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
• 8.8 China
• 8.9 Japan
• 8.10 South Korea
• 8.11 China Taiwan
• 8.12 India

9 Central and South America

• 9.1 Central and South America Sales Volume and Revenue (2020-2031)
• 9.2 Central and South America Key Manufacturers Sales Revenue in 2024
• 9.3 Central and South America Influenza A/B Nucleic Acid Detection Kit Sales and Revenue by Type (2020-2031)
• 9.4 Central and South America Influenza A/B Nucleic Acid Detection Kit Sales and Revenue by Application (2020-2031)
• 9.5 Central and South America Investment Opportunities and Key Challenges
• 9.6 Central and South America Influenza A/B Nucleic Acid Detection Kit Market Size by Country
  • 9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
  • 9.6.2 Brazil
  • 9.6.3 Argentina

10 Middle East and Africa

• 10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
• 10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
• 10.3 Middle East and Africa Influenza A/B Nucleic Acid Detection Kit Sales and Revenue by Type (2020-2031)
• 10.4 Middle East and Africa Influenza A/B Nucleic Acid Detection Kit Sales and Revenue by Application (2020-2031)
• 10.5 Middle East and Africa Investment Opportunities and Key Challenges
• 10.6 Middle East and Africa Influenza A/B Nucleic Acid Detection Kit Market Size by Country
  • 10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
  • 10.6.2 GCC Countries
  • 10.6.3 Turkey
  • 10.6.4 Egypt
  • 10.6.5 South Africa

11 Corporate Profile

• 11.1 Certest Biotec
  • 11.1.1 Certest Biotec Corporation Information
  • 11.1.2 Certest Biotec Business Overview
  • 11.1.3 Certest Biotec Influenza A/B Nucleic Acid Detection Kit Product Models, Descriptions and Specifications
  • 11.1.4 Certest Biotec Influenza A/B Nucleic Acid Detection Kit Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.1.5 Certest Biotec Influenza A/B Nucleic Acid Detection Kit Sales by Product in 2024
  • 11.1.6 Certest Biotec Influenza A/B Nucleic Acid Detection Kit Sales by Application in 2024
  • 11.1.7 Certest Biotec Influenza A/B Nucleic Acid Detection Kit Sales by Geographic Area in 2024
  • 11.1.8 Certest Biotec Influenza A/B Nucleic Acid Detection Kit SWOT Analysis
  • 11.1.9 Certest Biotec Recent Developments
• 11.2 Diagnostica Longwood
  • 11.2.1 Diagnostica Longwood Corporation Information
  • 11.2.2 Diagnostica Longwood Business Overview
  • 11.2.3 Diagnostica Longwood Influenza A/B Nucleic Acid Detection Kit Product Models, Descriptions and Specifications
  • 11.2.4 Diagnostica Longwood Influenza A/B Nucleic Acid Detection Kit Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.2.5 Diagnostica Longwood Influenza A/B Nucleic Acid Detection Kit Sales by Product in 2024
  • 11.2.6 Diagnostica Longwood Influenza A/B Nucleic Acid Detection Kit Sales by Application in 2024
  • 11.2.7 Diagnostica Longwood Influenza A/B Nucleic Acid Detection Kit Sales by Geographic Area in 2024
  • 11.2.8 Diagnostica Longwood Influenza A/B Nucleic Acid Detection Kit SWOT Analysis
  • 11.2.9 Diagnostica Longwood Recent Developments
• 11.3 MIZUHO MEDY
  • 11.3.1 MIZUHO MEDY Corporation Information
  • 11.3.2 MIZUHO MEDY Business Overview
  • 11.3.3 MIZUHO MEDY Influenza A/B Nucleic Acid Detection Kit Product Models, Descriptions and Specifications
  • 11.3.4 MIZUHO MEDY Influenza A/B Nucleic Acid Detection Kit Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.3.5 MIZUHO MEDY Influenza A/B Nucleic Acid Detection Kit Sales by Product in 2024
  • 11.3.6 MIZUHO MEDY Influenza A/B Nucleic Acid Detection Kit Sales by Application in 2024
  • 11.3.7 MIZUHO MEDY Influenza A/B Nucleic Acid Detection Kit Sales by Geographic Area in 2024
  • 11.3.8 MIZUHO MEDY Influenza A/B Nucleic Acid Detection Kit SWOT Analysis
  • 11.3.9 MIZUHO MEDY Recent Developments
• 11.4 QIAGEN
  • 11.4.1 QIAGEN Corporation Information
  • 11.4.2 QIAGEN Business Overview
  • 11.4.3 QIAGEN Influenza A/B Nucleic Acid Detection Kit Product Models, Descriptions and Specifications
  • 11.4.4 QIAGEN Influenza A/B Nucleic Acid Detection Kit Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.4.5 QIAGEN Influenza A/B Nucleic Acid Detection Kit Sales by Product in 2024
  • 11.4.6 QIAGEN Influenza A/B Nucleic Acid Detection Kit Sales by Application in 2024
  • 11.4.7 QIAGEN Influenza A/B Nucleic Acid Detection Kit Sales by Geographic Area in 2024
  • 11.4.8 QIAGEN Influenza A/B Nucleic Acid Detection Kit SWOT Analysis
  • 11.4.9 QIAGEN Recent Developments
• 11.5 DNA-Technology
  • 11.5.1 DNA-Technology Corporation Information
  • 11.5.2 DNA-Technology Business Overview
  • 11.5.3 DNA-Technology Influenza A/B Nucleic Acid Detection Kit Product Models, Descriptions and Specifications
  • 11.5.4 DNA-Technology Influenza A/B Nucleic Acid Detection Kit Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.5.5 DNA-Technology Influenza A/B Nucleic Acid Detection Kit Sales by Product in 2024
  • 11.5.6 DNA-Technology Influenza A/B Nucleic Acid Detection Kit Sales by Application in 2024
  • 11.5.7 DNA-Technology Influenza A/B Nucleic Acid Detection Kit Sales by Geographic Area in 2024
  • 11.5.8 DNA-Technology Influenza A/B Nucleic Acid Detection Kit SWOT Analysis
  • 11.5.9 DNA-Technology Recent Developments
• 11.6 FLASHTEST Technology
  • 11.6.1 FLASHTEST Technology Corporation Information
  • 11.6.2 FLASHTEST Technology Business Overview
  • 11.6.3 FLASHTEST Technology Influenza A/B Nucleic Acid Detection Kit Product Models, Descriptions and Specifications
  • 11.6.4 FLASHTEST Technology Influenza A/B Nucleic Acid Detection Kit Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.6.5 FLASHTEST Technology Recent Developments
• 11.7 Xi'an Tianlong Science and Technology Co., Ltd
  • 11.7.1 Xi'an Tianlong Science and Technology Co., Ltd Corporation Information
  • 11.7.2 Xi'an Tianlong Science and Technology Co., Ltd Business Overview
  • 11.7.3 Xi'an Tianlong Science and Technology Co., Ltd Influenza A/B Nucleic Acid Detection Kit Product Models, Descriptions and Specifications
  • 11.7.4 Xi'an Tianlong Science and Technology Co., Ltd Influenza A/B Nucleic Acid Detection Kit Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.7.5 Xi'an Tianlong Science and Technology Co., Ltd Recent Developments
• 11.8 Shanghai ZJ Bio-Tech Co., Ltd.
  • 11.8.1 Shanghai ZJ Bio-Tech Co., Ltd. Corporation Information
  • 11.8.2 Shanghai ZJ Bio-Tech Co., Ltd. Business Overview
  • 11.8.3 Shanghai ZJ Bio-Tech Co., Ltd. Influenza A/B Nucleic Acid Detection Kit Product Models, Descriptions and Specifications
  • 11.8.4 Shanghai ZJ Bio-Tech Co., Ltd. Influenza A/B Nucleic Acid Detection Kit Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.8.5 Shanghai ZJ Bio-Tech Co., Ltd. Recent Developments
• 11.9 Jiangsu Mole Bioscience Co., Ltd.
  • 11.9.1 Jiangsu Mole Bioscience Co., Ltd. Corporation Information
  • 11.9.2 Jiangsu Mole Bioscience Co., Ltd. Business Overview
  • 11.9.3 Jiangsu Mole Bioscience Co., Ltd. Influenza A/B Nucleic Acid Detection Kit Product Models, Descriptions and Specifications
  • 11.9.4 Jiangsu Mole Bioscience Co., Ltd. Influenza A/B Nucleic Acid Detection Kit Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.9.5 Jiangsu Mole Bioscience Co., Ltd. Recent Developments
• 11.10 Coyote Bioscience Co., Ltd.
  • 11.10.1 Coyote Bioscience Co., Ltd. Corporation Information
  • 11.10.2 Coyote Bioscience Co., Ltd. Business Overview
  • 11.10.3 Coyote Bioscience Co., Ltd. Influenza A/B Nucleic Acid Detection Kit Product Models, Descriptions and Specifications
  • 11.10.4 Coyote Bioscience Co., Ltd. Influenza A/B Nucleic Acid Detection Kit Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.10.5 Coyote Bioscience Co., Ltd. Recent Developments
• 11.11 Zybio Inc.
  • 11.11.1 Zybio Inc. Corporation Information
  • 11.11.2 Zybio Inc. Business Overview
  • 11.11.3 Zybio Inc. Influenza A/B Nucleic Acid Detection Kit Product Models, Descriptions and Specifications
  • 11.11.4 Zybio Inc. Influenza A/B Nucleic Acid Detection Kit Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.11.5 Zybio Inc. Recent Developments

12 Value Chain and Supply-Chain Analysis

• 12.1 Influenza A/B Nucleic Acid Detection Kit Industry Chain
• 12.2 Influenza A/B Nucleic Acid Detection Kit Upstream Materials Analysis
  • 12.2.1 Raw Materials
  • 12.2.2 Key Suppliers Market Share & Risk Assessment
• 12.3 Influenza A/B Nucleic Acid Detection Kit Integrated Production Analysis
  • 12.3.1 Manufacturing Footprint Analysis
  • 12.3.2 Regional Production Market Share (2020-2031)
  • 12.3.3 Regulatory and Trade Policy Impact on Production
  • 12.3.4 Production Technology Overview
  • 12.3.5 Regional Cost Drivers
• 12.4 Influenza A/B Nucleic Acid Detection Kit Sales Channels and Distribution Networks
  • 12.4.1 Sales Channels
  • 12.4.2 Distributors

13 Influenza A/B Nucleic Acid Detection Kit Market Dynamics

• 13.1 Industry Trends and Evolution
• 13.2 Market Growth Drivers and Emerging Opportunities
• 13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Influenza A/B Nucleic Acid Detection Kit Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 15.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Author Details

List of Tables

Table 1. Global Influenza A/B Nucleic Acid Detection Kit Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Influenza A/B Nucleic Acid Detection Kit Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Influenza A/B Nucleic Acid Detection Kit Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Influenza A/B Nucleic Acid Detection Kit Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Influenza A/B Nucleic Acid Detection Kit Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global Influenza A/B Nucleic Acid Detection Kit Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)

Table 7. Global Influenza A/B Nucleic Acid Detection Kit Sales by Region (2020-2025) & (K Units)

Table 8. Global Influenza A/B Nucleic Acid Detection Kit Sales by Region (2026-2031) & (K Units)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global Influenza A/B Nucleic Acid Detection Kit Sales by Manufacturers (2020-2025) & (K Units)

Table 11. Global Influenza A/B Nucleic Acid Detection Kit Sales Share by Manufacturers (2020-2025)

Table 12. Global Influenza A/B Nucleic Acid Detection Kit Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 13. Global Influenza A/B Nucleic Acid Detection Kit Revenue Market Share by Manufacturers (2020-2025)

Table 14. Global Key Manufacturers'Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 15. Global Influenza A/B Nucleic Acid Detection Kit by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza A/B Nucleic Acid Detection Kit as of 2024)

Table 16. Global Influenza A/B Nucleic Acid Detection Kit Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 17. Global Influenza A/B Nucleic Acid Detection Kit Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)

Table 18. Key Manufacturers Influenza A/B Nucleic Acid Detection Kit Manufacturing Base and Headquarters

Table 19. Global Influenza A/B Nucleic Acid Detection Kit Market Concentration Ratio (CR5 and HHI)

Table 20. Key Market Entrant/Exit (2020-2024) - Drivers & Impact Analysis

Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 22. Global Influenza A/B Nucleic Acid Detection Kit Sales by Type (2020-2025) & (K Units)

Table 23. Global Influenza A/B Nucleic Acid Detection Kit Sales by Type (2026-2031) & (K Units)

Table 24. Global Influenza A/B Nucleic Acid Detection Kit Revenue by Type (2020-2025) & (US$ Million)

Table 25. Global Influenza A/B Nucleic Acid Detection Kit Revenue by Type (2026-2031) & (US$ Million)

Table 26. Global Influenza A/B Nucleic Acid Detection Kit ASP by Type (2020-2031) & (US$/Unit)

Table 27. Technical Specifications by Key Product Type

Table 28. Global Influenza A/B Nucleic Acid Detection Kit Sales by Application (2020-2025) & (K Units)

Table 29. Global Influenza A/B Nucleic Acid Detection Kit Sales by Application (2026-2031) & (K Units)

Table 30. Influenza A/B Nucleic Acid Detection Kit High-Growth Sectors Demand CAGR (2024-2031)

Table 31. Global Influenza A/B Nucleic Acid Detection Kit Revenue by Application (2020-2025) & (US$ Million)

Table 32. Global Influenza A/B Nucleic Acid Detection Kit Revenue by Application (2026-2031) & (US$ Million)

Table 33. Global Influenza A/B Nucleic Acid Detection Kit ASP by Application (2020-2031) & (US$/Unit)

Table 34. Top Customers by Region

Table 35. Top Customers by Application

Table 36. North America Influenza A/B Nucleic Acid Detection Kit Growth Accelerators and Market Barriers

Table 37. North America Influenza A/B Nucleic Acid Detection Kit Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 38. North America Influenza A/B Nucleic Acid Detection Kit Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 39. Europe Influenza A/B Nucleic Acid Detection Kit Growth Accelerators and Market Barriers

Table 40. Europe Influenza A/B Nucleic Acid Detection Kit Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Europe Influenza A/B Nucleic Acid Detection Kit Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 42. Asia-Pacific Influenza A/B Nucleic Acid Detection Kit Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 43. Asia-Pacific Influenza A/B Nucleic Acid Detection Kit Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 44. Asia-Pacific Influenza A/B Nucleic Acid Detection Kit Growth Accelerators and Market Barriers

Table 45. Southeast Asia Influenza A/B Nucleic Acid Detection Kit Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Central and South America Influenza A/B Nucleic Acid Detection Kit Investment Opportunities and Key Challenges

Table 47. Central and South America Influenza A/B Nucleic Acid Detection Kit Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 48. Middle East and Africa Influenza A/B Nucleic Acid Detection Kit Investment Opportunities and Key Challenges

Table 49. Middle East and Africa Influenza A/B Nucleic Acid Detection Kit Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 50. Certest Biotec Corporation Information

Table 51. Certest Biotec Description and Major Businesses

Table 52. Certest Biotec Product Models, Descriptions and Specifications

Table 53. Certest Biotec Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 54. Certest Biotec Sales Value Proportion by Product in 2024

Table 55. Certest Biotec Sales Value Proportion by Application in 2024

Table 56. Certest Biotec Sales Value Proportion by Geographic Area in 2024

Table 57. Certest Biotec Influenza A/B Nucleic Acid Detection Kit SWOT Analysis

Table 58. Certest Biotec Recent Developments

Table 59. Diagnostica Longwood Corporation Information

Table 60. Diagnostica Longwood Description and Major Businesses

Table 61. Diagnostica Longwood Product Models, Descriptions and Specifications

Table 62. Diagnostica Longwood Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 63. Diagnostica Longwood Sales Value Proportion by Product in 2024

Table 64. Diagnostica Longwood Sales Value Proportion by Application in 2024

Table 65. Diagnostica Longwood Sales Value Proportion by Geographic Area in 2024

Table 66. Diagnostica Longwood Influenza A/B Nucleic Acid Detection Kit SWOT Analysis

Table 67. Diagnostica Longwood Recent Developments

Table 68. MIZUHO MEDY Corporation Information

Table 69. MIZUHO MEDY Description and Major Businesses

Table 70. MIZUHO MEDY Product Models, Descriptions and Specifications

Table 71. MIZUHO MEDY Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 72. MIZUHO MEDY Sales Value Proportion by Product in 2024

Table 73. MIZUHO MEDY Sales Value Proportion by Application in 2024

Table 74. MIZUHO MEDY Sales Value Proportion by Geographic Area in 2024

Table 75. MIZUHO MEDY Influenza A/B Nucleic Acid Detection Kit SWOT Analysis

Table 76. MIZUHO MEDY Recent Developments

Table 77. QIAGEN Corporation Information

Table 78. QIAGEN Description and Major Businesses

Table 79. QIAGEN Product Models, Descriptions and Specifications

Table 80. QIAGEN Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 81. QIAGEN Sales Value Proportion by Product in 2024

Table 82. QIAGEN Sales Value Proportion by Application in 2024

Table 83. QIAGEN Sales Value Proportion by Geographic Area in 2024

Table 84. QIAGEN Influenza A/B Nucleic Acid Detection Kit SWOT Analysis

Table 85. QIAGEN Recent Developments

Table 86. DNA-Technology Corporation Information

Table 87. DNA-Technology Description and Major Businesses

Table 88. DNA-Technology Product Models, Descriptions and Specifications

Table 89. DNA-Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 90. DNA-Technology Sales Value Proportion by Product in 2024

Table 91. DNA-Technology Sales Value Proportion by Application in 2024

Table 92. DNA-Technology Sales Value Proportion by Geographic Area in 2024

Table 93. DNA-Technology Influenza A/B Nucleic Acid Detection Kit SWOT Analysis

Table 94. DNA-Technology Recent Developments

Table 95. FLASHTEST Technology Corporation Information

Table 96. FLASHTEST Technology Description and Major Businesses

Table 97. FLASHTEST Technology Product Models, Descriptions and Specifications

Table 98. FLASHTEST Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 99. FLASHTEST Technology Recent Developments

Table 100. Xi'an Tianlong Science and Technology Co., Ltd Corporation Information

Table 101. Xi'an Tianlong Science and Technology Co., Ltd Description and Major Businesses

Table 102. Xi'an Tianlong Science and Technology Co., Ltd Product Models, Descriptions and Specifications

Table 103. Xi'an Tianlong Science and Technology Co., Ltd Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 104. Xi'an Tianlong Science and Technology Co., Ltd Recent Developments

Table 105. Shanghai ZJ Bio-Tech Co., Ltd. Corporation Information

Table 106. Shanghai ZJ Bio-Tech Co., Ltd. Description and Major Businesses

Table 107. Shanghai ZJ Bio-Tech Co., Ltd. Product Models, Descriptions and Specifications

Table 108. Shanghai ZJ Bio-Tech Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 109. Shanghai ZJ Bio-Tech Co., Ltd. Recent Developments

Table 110. Jiangsu Mole Bioscience Co., Ltd. Corporation Information

Table 111. Jiangsu Mole Bioscience Co., Ltd. Description and Major Businesses

Table 112. Jiangsu Mole Bioscience Co., Ltd. Product Models, Descriptions and Specifications

Table 113. Jiangsu Mole Bioscience Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 114. Jiangsu Mole Bioscience Co., Ltd. Recent Developments

Table 115. Coyote Bioscience Co., Ltd. Corporation Information

Table 116. Coyote Bioscience Co., Ltd. Description and Major Businesses

Table 117. Coyote Bioscience Co., Ltd. Product Models, Descriptions and Specifications

Table 118. Coyote Bioscience Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 119. Coyote Bioscience Co., Ltd. Recent Developments

Table 120. Zybio Inc. Corporation Information

Table 121. Zybio Inc. Description and Major Businesses

Table 122. Zybio Inc. Product Models, Descriptions and Specifications

Table 123. Zybio Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 124. Zybio Inc. Recent Developments

Table 125. Key Raw Materials Distribution

Table 126. Raw Materials Key Suppliers

Table 127. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 128. Milestones in Production Technology Evolution

Table 129. Distributors List

Table 130. Market Trends and Market Evolution

Table 131. Market Drivers and Opportunities

Table 132. Market Challenges, Risks, and Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

List of Figures

Figure 1. Influenza A/B Nucleic Acid Detection Kit Product Picture

Figure 2. Global Influenza A/B Nucleic Acid Detection Kit Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. 32 Test/ Box Product Picture

Figure 4. 96 Test/ Box Product Picture

Figure 5. Other Packaging Specifications Product Picture

Figure 6. Global Influenza A/B Nucleic Acid Detection Kit Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 7. Hospital

Figure 8. CDC

Figure 9. Third-party Testing Agency

Figure 10. Influenza A/B Nucleic Acid Detection Kit Report Years Considered

Figure 11. Global Influenza A/B Nucleic Acid Detection Kit Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Influenza A/B Nucleic Acid Detection Kit Revenue (2020-2031) & (US$ Million)

Figure 13. Global Influenza A/B Nucleic Acid Detection Kit Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 14. Global Influenza A/B Nucleic Acid Detection Kit Revenue Market Share by Region (2020-2031)

Figure 15. Global Influenza A/B Nucleic Acid Detection Kit Sales (2020-2031) & (K Units)

Figure 16. Global Influenza A/B Nucleic Acid Detection Kit Sales (CAGR) by Region (2020-2031) (K Units)

Figure 17. Global Influenza A/B Nucleic Acid Detection Kit Sales Market Share by Region (2020-2031)

Figure 18. Top 5 and Top 10 Manufacturers Influenza A/B Nucleic Acid Detection Kit Sales Volume Market Share in 2024

Figure 19. Global Influenza A/B Nucleic Acid Detection Kit Revenue Market Share Ranking (2024)

Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 21. 32 Test/ Box Revenue Market Share by Manufacturer in 2024

Figure 22. 96 Test/ Box Revenue Market Share by Manufacturer in 2024

Figure 23. Other Packaging Specifications Revenue Market Share by Manufacturer in 2024

Figure 24. Global Influenza A/B Nucleic Acid Detection Kit Sales Market Share by Type (2020-2031)

Figure 25. Global Influenza A/B Nucleic Acid Detection Kit Revenue Market Share by Type (2020-2031)

Figure 26. Global Influenza A/B Nucleic Acid Detection Kit Sales Market Share by Application (2020-2031)

Figure 27. Global Influenza A/B Nucleic Acid Detection Kit Revenue Market Share by Application (2020-2031)

Figure 28. North America Influenza A/B Nucleic Acid Detection Kit Sales YoY (2020-2031) & (K Units)

Figure 29. North America Influenza A/B Nucleic Acid Detection Kit Revenue YoY (2020-2031) & (US$ Million)

Figure 30. North America Top 5 Manufacturers Influenza A/B Nucleic Acid Detection Kit Sales Revenue (US$ Million) in 2024

Figure 31. North America Influenza A/B Nucleic Acid Detection Kit Sales Volume (K Units) by Type (2020- 2031)

Figure 32. North America Influenza A/B Nucleic Acid Detection Kit Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 33. North America Influenza A/B Nucleic Acid Detection Kit Sales Volume (K Units) by Application (2020-2031)

Figure 34. North America Influenza A/B Nucleic Acid Detection Kit Sales Revenue (US$ Million) by Application (2020-2031)

Figure 35. US Influenza A/B Nucleic Acid Detection Kit Revenue (2020-2031) & (US$ Million)

Figure 36. Canada Influenza A/B Nucleic Acid Detection Kit Revenue (2020-2031) & (US$ Million)

Figure 37. Mexico Influenza A/B Nucleic Acid Detection Kit Revenue (2020-2031) & (US$ Million)

Figure 38. Europe Influenza A/B Nucleic Acid Detection Kit Sales YoY (2020-2031) & (K Units)

Figure 39. Europe Influenza A/B Nucleic Acid Detection Kit Revenue YoY (2020-2031) & (US$ Million)

Figure 40. Europe Top 5 Manufacturers Influenza A/B Nucleic Acid Detection Kit Sales Revenue (US$ Million) in 2024

Figure 41. Europe Influenza A/B Nucleic Acid Detection Kit Sales Volume (K Units) by Type (2020-2031)

Figure 42. Europe Influenza A/B Nucleic Acid Detection Kit Sales Revenue (US$ Million) by Type (2020-2031)

Figure 43. Europe Influenza A/B Nucleic Acid Detection Kit Sales Volume (K Units) by Application (2020-2031)

Figure 44. Europe Influenza A/B Nucleic Acid Detection Kit Sales Revenue (US$ Million) by Application (2020-2031)

Figure 45. Germany Influenza A/B Nucleic Acid Detection Kit Revenue (2020-2031) & (US$ Million)

Figure 46. France Influenza A/B Nucleic Acid Detection Kit Revenue (2020-2031) & (US$ Million)

Figure 47. U.K. Influenza A/B Nucleic Acid Detection Kit Revenue (2020-2031) & (US$ Million)

Figure 48. Italy Influenza A/B Nucleic Acid Detection Kit Revenue (2020-2031) & (US$ Million)

Figure 49. Russia Influenza A/B Nucleic Acid Detection Kit Revenue (2020-2031) & (US$ Million)

Figure 50. Asia-Pacific Influenza A/B Nucleic Acid Detection Kit Sales YoY (2020-2031) & (K Units)

Figure 51. Asia-Pacific Influenza A/B Nucleic Acid Detection Kit Revenue YoY (2020-2031) & (US$ Million)

Figure 52. Asia-Pacific Top 8 Manufacturers Influenza A/B Nucleic Acid Detection Kit Sales Revenue (US$ Million) in 2024

Figure 53. Asia-Pacific Influenza A/B Nucleic Acid Detection Kit Sales Volume (K Units) by Type (2020- 2031)

Figure 54. Asia-Pacific Influenza A/B Nucleic Acid Detection Kit Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 55. Asia-Pacific Influenza A/B Nucleic Acid Detection Kit Sales Volume (K Units) by Application (2020-2031)

Figure 56. Asia-Pacific Influenza A/B Nucleic Acid Detection Kit Sales Revenue (US$ Million) by Application (2020-2031)

Figure 57. Indonesia Influenza A/B Nucleic Acid Detection Kit Revenue (2020-2031) & (US$ Million)

Figure 58. Japan Influenza A/B Nucleic Acid Detection Kit Revenue (2020-2031) & (US$ Million)

Figure 59. South Korea Influenza A/B Nucleic Acid Detection Kit Revenue (2020-2031) & (US$ Million)

Figure 60. China Taiwan Influenza A/B Nucleic Acid Detection Kit Revenue (2020-2031) & (US$ Million)

Figure 61. India Influenza A/B Nucleic Acid Detection Kit Revenue (2020-2031) & (US$ Million)

Figure 62. Central and South America Influenza A/B Nucleic Acid Detection Kit Sales YoY (2020-2031) & (K Units)

Figure 63. Central and South America Influenza A/B Nucleic Acid Detection Kit Revenue YoY (2020-2031) & (US$ Million)

Figure 64. Central and South America Top 5 Manufacturers Influenza A/B Nucleic Acid Detection Kit Sales Revenue (US$ Million) in 2024

Figure 65. Central and South America Influenza A/B Nucleic Acid Detection Kit Sales Volume (K Units) by Type (2021-2031)

Figure 66. Central and South America Influenza A/B Nucleic Acid Detection Kit Sales Revenue (US$ Million) by Type (2020-2031)

Figure 67. Central and South America Influenza A/B Nucleic Acid Detection Kit Sales Volume (K Units) by Application (2020-2031)

Figure 68. Central and South America Influenza A/B Nucleic Acid Detection Kit Sales Revenue (US$ Million) by Application (2020-2031)

Figure 69. Brazil Influenza A/B Nucleic Acid Detection Kit Revenue (2020-2025) & (US$ Million)

Figure 70. Argentina Influenza A/B Nucleic Acid Detection Kit Revenue (2020-2025) & (US$ Million)

Figure 71. Middle East, and Africa Influenza A/B Nucleic Acid Detection Kit Sales YoY (2020-2031) & (K Units)

Figure 72. Middle East and Africa Influenza A/B Nucleic Acid Detection Kit Revenue YoY (2020-2031) & (US$ Million)

Figure 73. Middle East and Africa Top 5 Manufacturers Influenza A/B Nucleic Acid Detection Kit Sales Revenue (US$ Million) in 2024

Figure 74. Middle East and Africa Influenza A/B Nucleic Acid Detection Kit Sales Volume (K Units) by Type (2021-2031)

Figure 75. South America Influenza A/B Nucleic Acid Detection Kit Sales Revenue (US$ Million) by Type (2020-2031)

Figure 76. Middle East and Africa Influenza A/B Nucleic Acid Detection Kit Sales Volume (K Units) by Application (2020-2031)

Figure 77. Middle East and Africa Influenza A/B Nucleic Acid Detection Kit Sales Revenue (US$ Million) by Application (2020-2031)

Figure 78. GCC Countries Influenza A/B Nucleic Acid Detection Kit Revenue (2020-2025) & (US$ Million)

Figure 79. Turkey Influenza A/B Nucleic Acid Detection Kit Revenue (2020-2025) & (US$ Million)

Figure 80. Egypt Influenza A/B Nucleic Acid Detection Kit Revenue (2020-2025) & (US$ Million)

Figure 81. South Africa Influenza A/B Nucleic Acid Detection Kit Revenue (2020-2025) & (US$ Million)

Figure 82. Influenza A/B Nucleic Acid Detection Kit Industry Chain Mapping

Figure 83. Regional Influenza A/B Nucleic Acid Detection Kit Manufacturing Base Distribution (%)

Figure 84. Global Influenza A/B Nucleic Acid Detection Kit Production Market Share by Region (2020-2031)

Figure 85. Influenza A/B Nucleic Acid Detection Kit Production Process

Figure 86. Regional Influenza A/B Nucleic Acid Detection Kit Production Cost Structure

Figure 87. Channels of Distribution (Direct Vs Distribution)

Figure 88. Bottom-up and Top-down Approaches for This Report

Figure 89. Data Triangulation

Figure 90. Key Executives Interviewed